(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 11.78%
-0.81% $ 1.220
Live Chart Being Loaded With Signals
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide...
Stats | |
---|---|
Volumen de hoy | 202 091 |
Volumen promedio | 220 879 |
Capitalización de mercado | 54.73M |
EPS | $0 ( 2024-03-28 ) |
Próxima fecha de ganancias | ( $-0.360 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 4.52 |
ATR14 | $0.00500 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-01 | Golipour Azadeh | Sell | 37 334 | Restricted Stock Unit |
2024-02-01 | Golipour Azadeh | Buy | 37 334 | Common Stock |
2024-02-05 | Golipour Azadeh | Sell | 12 232 | Common Stock |
2024-02-01 | Ridha Essra | Sell | 32 834 | Restricted Stock Unit |
2024-02-01 | Ridha Essra | Buy | 32 834 | Common Stock |
INSIDER POWER |
---|
54.75 |
Last 100 transactions |
Buy: 6 327 240 | Sell: 1 294 974 |
Volumen Correlación
AVROBIO Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
TLS | 0.933 |
MBIN | 0.909 |
HUBG | 0.893 |
ALLK | 0.892 |
PMBC | 0.888 |
BNGO | 0.885 |
NBTB | 0.884 |
ITOS | 0.876 |
ATNX | 0.873 |
CLOV | 0.873 |
10 Correlaciones Más Negativas | |
---|---|
AAON | -0.865 |
DPCS | -0.861 |
GRPH | -0.851 |
BNIXU | -0.845 |
KVSC | -0.845 |
CINC | -0.844 |
SGEN | -0.842 |
IPAR | -0.841 |
BCOR | -0.839 |
PRTC | -0.829 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AVROBIO Inc Correlación - Moneda/Commodity
AVROBIO Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-617 000 (0.00 %) |
EPS: | $0.270 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-617 000 (0.00 %) |
EPS: | $0.270 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-4.17M (0.00 %) |
EPS: | $-2.42 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-2.78 |
Financial Reports:
No articles found.
AVROBIO Inc
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico